Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

University of Toronto

$90,000.00

Bad Romance: defining the molecular link between Neisseria gonorrhoeae and HIV

EF 2016-17

Résumé
Human immunodeficiency virus (HIV) is a devastating disease that affects millions of people worldwide. Although antiretroviral therapy has been effective at prolonging the lives of infected individuals, HIV remains without a cure due to cells containing reservoirs of latent virus that cannot be targeted by drugs currently available. Clinical observations show that gonorrhea infection in humans increases HIV shedding and transmission, as well as enhancing an individual's susceptibility to HIV infection upon exposure. We have recently discovered a gonococcal molecule called HBP that increases HIV replication. This study will further examine the effects of HBP on HIV infection using a new mouse model of HIV/gonorrhea co-infection and white blood cells from HIV-infected people. The end goal of these studies is examine HBP as a promising 'latency reversing agent' that can be used with current antiretroviral therapies to ultimately cure HIV-infected patients.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
362309
Name
Xu Stacey
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Bad Romance: defining the molecular link between Neisseria gonorrhoeae and HIV
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$90,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Co-Infection Model; Hiv Latency; Human Immunodeficiency Virus; Humanized Mouse Model (Nsg); Mucosal Shedding; Neisseria Gonorrhoeae; Pelvic Inflammatory Disease; Sexually Transmitted Infection
Abstract
Human immunodeficiency virus (HIV) is a devastating disease that affects millions of people worldwide. Although antiretroviral therapy has been effective at prolonging the lives of infected individuals, HIV remains without a cure due to cells containing reservoirs of latent virus that cannot be targeted by drugs currently available. Clinical observations show that gonorrhea infection in humans increases HIV shedding and transmission, as well as enhancing an individual's susceptibility to HIV infection upon exposure. We have recently discovered a gonococcal molecule called HBP that increases HIV replication. This study will further examine the effects of HBP on HIV infection using a new mouse model of HIV/gonorrhea co-infection and white blood cells from HIV-infected people. The end goal of these studies is examine HBP as a promising 'latency reversing agent' that can be used with current antiretroviral therapies to ultimately cure HIV-infected patients.
Competitiondate
201611
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Xu, Stacey
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $90,000~ $0~